NEW FORMULATION OF GAMMA-AMINOBUTYRIC ACID
The present invention relates to an oral dosage form comprising gamma-aminobutyric acid (GABA) and pharmaceutically acceptable excipients, wherein 100% of the GABA is released within 0.25-5hours in 0.01 M HC1 at 37°C in a USP dissolution apparatus 2. The invention further relates to specific dosage...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English Spanish |
Published |
22.03.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to an oral dosage form comprising gamma-aminobutyric acid (GABA) and pharmaceutically acceptable excipients, wherein 100% of the GABA is released within 0.25-5hours in 0.01 M HC1 at 37°C in a USP dissolution apparatus 2. The invention further relates to specific dosage forms, methods for treatment of autoimmune diseases with the dosage form, as well as use of the dosage form in such methods.
La presente invención se refiere a una forma de dosificación oral que comprende ácido gamma-aminobutírico (GABA) y los excipientes farmacéuticamente aceptables, en la que el 100% del GABA se libera dentro de 0.25-5 horas en 0.01 M HCl a 37 °C en un aparato de disolución USP 2. La invención se refiere además a formas de dosificación específicas, métodos para el tratamiento de enfermedades autoinmunes con la forma de dosificación, así como el uso de la forma de dosificación en tales métodos. |
---|---|
Bibliography: | Application Number: MX2023002649 |